Daytime TV star Susan Lucci and husband Helmut Huber discuss living with atrial fibrillation with StopAfib.org founder Mellanie True Hills in a new video released as part of the Facing AFib™ program to encourage getting serious about atrial fibrillation and stroke.
Read More
By Mellanie True Hills I just got home from a one-week multi-city trip and have so much catching up to do. But with the furor over the new airport security screening procedures that have just gone into effect in the US, I have some thoughts that I simply must share before my head explodes. This …
Read More
In late breaking clinical trials presented today at the American Heart Association Scientific Sessions, results of the ROCKET AF trial indicated that in an atrial fibrillation patient population that was at a very high risk of stroke, rivaroxaban (Xarelto) was as good as warfarin at preventing strokes. Learn more at: Rivaroxaban comparable to warfarin in …
Read More
The atrial fibrillation patient community is invited to try out myLifeLog, an application just for tracking afib patient experiences. After entering your medical information, you can share it with your healthcare providers—either online or printed—and continue to update it from appointment to appointment. Learn more at: New Tool Lets You Track Your Atrial Fibrillation Patient …
Read More
Check out the latest content at StopAfib.org, including: Profile of Jason Mattingly, a young atrial fibrillation patient who is now afib free due to catheter ablation Updated information about StopAfib.org The latest at the StopAfib Discussion Forum Learn more at: StopAfib.org Announces Atrial Fibrillation Patient Profile of Jason Mattingly
Read More
Here's a good article on the connection between chronic obstructive pulmonary disease (COPD) and atrial fibrillation. If you have COPD, here's where you can Get Started Learning About Atrial Fibrillation.
Read More
New medical guidelines from the European Society of Cardiology (ESC) incorporating the latest afib research put Europe ahead of the U.S. when it comes to standardized treatment of atrial fibrillation. Stroke prevention and symptom relief are at the heart of the new ESC guidelines, which also make it clear that the risk of stroke for …
Read More
On the heels of the US FDA approving dabigatran, the long-awaited alternative to Coumadin (warfarin), comes word that Health Canada has as well. In Canada, dabigatran is known as PRADAX™. Because this is the first alternative to warfarin in Canada, it is big news for the afib community there. Learn more at: Health Canada Approves …
Read More
October 29 is World Stroke Day. You can learn more about steps you can take to prevent a stroke at World Stroke Day, October 29, 2010. Professor Bo Norrving, president of the sponsoring World Stroke Organization, is a member of our StopAfib.org Medical Advisory Board.
Read More
The long-awaited alternative to Coumadin (warfarin) has just been approved by the US FDA. The FDA just approved Pradaxa (dabigatran) for use by those with atrial fibrillation for preventing afib-related strokes. The FDA based approval on results of the RE-LY trial, which saw patients on Pradaxa having fewer strokes than those on warfarin. And Pradaxa …
Read More